Literature DB >> 5136455

Interaction of albumin and fusidic acid.

F Güttler, L Tybring, H Engberg-Pedersen.   

Abstract

1. By combining the agar plate diffusion technique for determination of antibiotic activity and zone microelectrophoresis in agar gel, the activity of fusidic acid in individual serum proteins of blood and pus obtained from patients given sodium fusidate revealed albumin to be responsible for the protein binding of this antibiotic.2. Based on the assumption that only free fusidic acid is microbiologically active, the relationship between the concentration of albumin and the ratio of free to total fusidic acid was determined at four concentrations of free fusidic acid, using as test organisms four differently sensitive variants of a Staphylococcus aureus strain. At each concentration an increasing amount of albumin (0-40 mg/ml culture medium) decreased the activity of fusidic acid as determined in serial dilutions (IC50).3. The law of mass action expressed as Langmuir's adsorption isotherm was valid if a correction for the influence of albumin on the sensitivity of the strain of Staph. aureus was introduced. For other test organisms no correction is necessary. The constant in Langmuir's adsorption isotherm was K=78400+/-8200 l./mol and n=3.15 (95% confidence limits: 2.09-5.52).4. The mean blood concentration was 20.8 mug/ml and the mean pus concentration 17.2 mug/ml in nineteen sets of blood and pus samples. The ratio of pus to blood corresponds to the ratio of published values for the protein concentrations in serum and in inflammatory oedema.5. It is concluded that for albumin bound drugs the ;storage depot' of the organism also includes the fluid of the tissue spaces including the inflammatory oedema. As recent studies have revealed an extravascular albumin pool similar in size to the plasma pool, this ;storage depot' should not be neglected.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5136455      PMCID: PMC1665939          DOI: 10.1111/j.1476-5381.1971.tb07164.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

1.  Antibacterial activity in vitro of fucidin.

Authors:  M BARBER; P M WATERWORTH
Journal:  Lancet       Date:  1962-05-05       Impact factor: 79.321

2.  Fucidin: a new orally active antibiotic.

Authors:  W GODTFREDSEN; K ROHOLT; L TYBRING
Journal:  Lancet       Date:  1962-05-05       Impact factor: 79.321

3.  The binding of antibiotics to serum proteins.

Authors:  G N Rolinson; R Sutherland
Journal:  Br J Pharmacol Chemother       Date:  1965-12

4.  Estimation of sodium fusidate levels in human serum, aqueous humour, and vitreous body.

Authors:  J Williamson; F Russell; W M Doig; R W Paterson
Journal:  Br J Ophthalmol       Date:  1970-02       Impact factor: 4.638

5.  Intraocular penetration of the antibiotic fucidin.

Authors:  A J Chadwick; B Jackson
Journal:  Br J Ophthalmol       Date:  1969-01       Impact factor: 4.638

6.  Fucidin, pro-staphlin, and penicillin concentration in burn crusts.

Authors:  B Sorensen; P Sejrsen; M Thomsen
Journal:  Acta Chir Scand       Date:  1966-06
  6 in total
  10 in total

Review 1.  Protein binding: do we ever learn?

Authors:  Markus A Zeitlinger; Hartmut Derendorf; Johan W Mouton; Otto Cars; William A Craig; David Andes; Ursula Theuretzbacher
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

2.  Effect of protein binding of daptomycin on MIC and antibacterial activity.

Authors:  B L Lee; M Sachdeva; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

3.  Binding of antibiotics to bovine and ovine serum.

Authors:  G Ziv; F G Sulman
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

Review 4.  The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy.

Authors:  R Wise
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

5.  Effect of fusidic acid on the immune response in mice.

Authors:  A Bellahsène; A Forsgren
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

6.  Population pharmacokinetics of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid.

Authors:  Amélie Marsot; Amelie Ménard; Julien Dupouey; Cedric Muziotti; Romain Guilhaumou; Olivier Blin
Journal:  Br J Clin Pharmacol       Date:  2017-01-16       Impact factor: 4.335

7.  Pharmacokinetics of intravenous fusidic acid in patients with cholestasis.

Authors:  J D Peter; F Jehl; T Pottecher; J P Dupeyron; H Monteil
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

Review 8.  Fusidic acid: new opportunities with an old antibiotic.

Authors:  J D Anderson
Journal:  Can Med Assoc J       Date:  1980-04-05       Impact factor: 8.262

9.  Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Authors:  B Fantin; R Leclercq; J Duval; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

10.  Biochemical characterization and evaluation of cytotoxicity of antistaphylococcal chimeric protein P128.

Authors:  Shilpa E George; Ravisha Chikkamadaiah; Murali Durgaiah; Amruta A Joshi; Ullas P Thankappan; Shampur N Madhusudhana; Bharathi Sriram
Journal:  BMC Res Notes       Date:  2012-06-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.